Prelude Therapeutics Incorporat (PRLD)
Recommendation: none
PE: N/A
Previous close: 0.98
$1.03 USD
+5.10% change today
-72.24% change last 6 months
5D 1M 6M 1Y
Average analyst target: 5.4
Healthcare, Biotechnology
Market cap: 56.69MRecommendation: none
PE: N/A
Previous close: 0.98
$1.03 USD
+5.10% change today
-72.24% change last 6 months
5D 1M 6M 1Y
Inversely correlated stocks:
DAC ATHS FGN More >>More data :
Price-to-book : 0.36Average analyst target: 5.4